Delhi Chief Minister Arvind Kejriwal said today that the Delhi has got the Centre’s approval to carry out clinical trials of plasma therapy to help critically ill coronavirus patients. The plasma therapy is only for COVID-19 patients who are on ventilator support and seriously ill. Multi-Centre trials were expected to begin for this, after clearance from the Drug Controller of India.
“Trial of Plasma Enrichment technique will begin in the next three or four days. If successful, we can save the livesof serious COVID-19 patients,” Mr. Kejriwal said.
